ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

ACR Convergence 2022

November 10-14, 2022. Philadelphia, PA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o [p] q r s t u v w x y z
  • Abstract Number: 1590
    Pain and Treatment Switching Among Patients in the CorEvitasTM Rheumatoid Arthritis Registry
  • Abstract Number: 2261
    Pain in Osteoarthritis – Identification of GPR34 and GPR150 as Novel Targets in the Dorsal Root Ganglia
  • Abstract Number: 1718
    Parenchymal INFγ Response Regulates Murine Lupus Nephritis
  • Abstract Number: 0662
    Partial Correlations Network Models Show Th1, Th2 and Th17 Responses to Be Interlinked in Dermal Pathogenesis of Cutaneous Lupus Erythematous
  • Abstract Number: 0648
    Pathogenic Anti-C1q Antibodies Potentiate Activation of the Classical Complement Pathway in a Subset of Lupus Nephritis Patients
  • Abstract Number: 1165
    Pathogenicity of IL-17 Producing Cells in HLA-B27 Transgenic Rat Model of Spondyloarthritis
  • Abstract Number: 1927
    Patient and Parent Perceptions of an Established Rheumatology Transition Clinic for Adolescents and Young Adults
  • Abstract Number: 1367
    Patient and Physician Reported Outcomes of Juvenile Systemic Sclerosis Patients Significantly Improve over 12 Months Observation Period in the Juvenile Systemic Scleroderma Inception Cohort
  • Abstract Number: 0086
    Patient and Provider Perspectives on Barriers to Communication and Care of Latinx Patients with Lupus and Rheumatoid Arthritis
  • Abstract Number: 1509
    Patient Clusters Identified by Machine Learning from a Pooled Analysis of the Clinical Development Program of Secukinumab in Psoriatic Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis with Axial Manifestations
  • Abstract Number: 0742
    Patient Factors Influencing Recruitment in a Telemedicine Randomized Clinical Trial
  • Abstract Number: PP02
    Patient Mobilization for Vaccine Access and Improved Care During the COVID Pandemic
  • Abstract Number: 1333
    Patient Perceptions of Rheumatoid Arthritis Blood Work: A Cross-sectional Survey in the ArthritisPower Registry
  • Abstract Number: 0181
    Patient Perspective of Unique Support and Education Needs of Latinx/Latino(a)/Hispanic Rheumatoid Arthritis Patients: Implications for a Culturally Tailored and Disease Specific Intervention
  • Abstract Number: 0198
    Patient Perspectives on Janus Kinase Inhibitor Use in the Treatment of Inflammatory Arthritis
  • Abstract Number: 2243
    Patient Reported Outcomes from a Randomized Phase 3 Trial of Sarilumab in Polymyalgia Rheumatica
  • Abstract Number: 0610
    Patient-derived Organoids Reveal Transcriptional Regulation of Synovial Lining Fibroblast Differentiation
  • Abstract Number: 1356
    Patient-perceived Disease Burden and Self-reported Medication Adherence in Systemic Autoimmune Diseases: A Monocentric Observational Study
  • Abstract Number: 0187
    Patient-reported Outcomes and Quality of Life in Patients with Rheumatoid Arthritis Treated with GP2015: Final Results from a Real-world Study
  • Abstract Number: 0441
    Patient-Reported Outcomes in ANCA-Associated Vasculitis: Interactions Between Patients’ and Physicians’ Perspectives in a Mexican Cohort
  • Abstract Number: 1813
    Patient-Reported Outcomes in CPPD Compared to Gout and Osteoarthritis
  • Abstract Number: 1344
    Patient-reported Outcomes in Lupus Low Disease Activity State: Impact of Fatigue
  • Abstract Number: 1999
    Patient-Reported Outcomes in Rheumatoid Arthritis Correlate with Clinical Disease Activity Index Response in the Study to Accelerate Information of Molecular Signatures (AIMS)
  • Abstract Number: 0191
    Patient-reported Outcomes to Assess Dyspnea in Connective Tissue Diseases, Interstitial Lung Disease and Pulmonary Hypertension, a Systematic Literature Review of Measurement Properties
  • Abstract Number: 0036
    Patient-specific and Disease-related Determinants for Cardiovascular Disease (CVD) Risk Stratification in the APPLE (Atherosclerosis Prevention in Paediatric Lupus Erythematosus) Clinical Trial Cohort
  • Abstract Number: PP22
    Patients Raising Awareness for Patients – A Collaborative Partnership Between Take a Pain Check Foundation and Canadian Arthritis Patient Alliance
  • Abstract Number: 0256
    Patients with ACPA-positive and ACPA-negative Rheumatoid Arthritis Show Different Circulating Auto-antibody Repertoires
  • Abstract Number: 0138
    Patients with Familial Mediterranean Fever (FMF) Under Canakinumab Treatment – Long-term Efficacy and Safety Interim Data of the RELIANCE Registry
  • Abstract Number: 1464
    Patients with Late-onset-Systemic Lupus Erythematosus Have Different Disease Presentations
  • Abstract Number: 1444
    Patients with Lupus Pericarditis Have the Impact on the Poor Survival Outcome: A Retrospective Cohort Study
  • Abstract Number: 0906
    Patients with Seronegative Rheumatoid Arthritis Have a Different Ultrasound-assessed Joint Disease Phenotype Than Seropositive Patients
  • Abstract Number: 1280
    Patients with Systemic Lupus Erythematosus Perceive the Quality of Care They Receive to Be Suboptimal
  • Abstract Number: 2165
    Patients with Systemic Sclerosis Have Impaired Forced Vital Capacity, Even in the Absence of Interstitial Lung Disease
  • Abstract Number: 1338
    Patients’ Perspectives and Experiences of Medication Use in Osteoporosis – a Qualitative Systematic Review and Thematic Synthesis
  • Abstract Number: 0967
    Patterns of Breastfeeding Among Women with and Without Systemic Lupus Erythematosus
  • Abstract Number: 1452
    Patterns of Outpatient and Acute Care Use Among Patients with SLE on Long-Term Moderate to High Dose Glucocorticoid Medication: A 1 Year Retrospective Analysis
  • Abstract Number: 1933
    PECOS (Pediatric SARS-CoV-2 MIS-C Long-term Outcomes Study): Preliminary Results
  • Abstract Number: 1941
    Pediatric Idiopathic Pulmonary Hemosiderosis – a Single-Center, Retrospective Study Comparing Use of Commonly Used Steroid-Sparing Agents
  • Abstract Number: 1298
    Pediatric Rheumatology Care and Outcomes Improvement Network Demonstrates Outcome Improvement for Children with Juvenile Idiopathic Arthritis
  • Abstract Number: 0911
    Peer Coach Intervention to Improve Primary Cardiovascular Disease Screening for Patients with Rheumatoid Arthritis
  • Abstract Number: 1814
    Pegloticase for Uncontrolled Gout in Patients with History of Kidney Transplant: Pharmacokinetics and Immunogenicity in the PROTECT Clinical Trial
  • Abstract Number: 1691
    Pentagalloyl Glucose Inhibits MSU-Induced Inflammation via Transforming Growth Factor-β-Activated Kinase 1 (TAK1)
  • Abstract Number: 1705
    Peptidoglycan Amplifies CD4+ T Cell Activation by MHCII+ Fibroblast-like Synoviocytes in an in Vitro Model of Lyme Arthritis
  • Abstract Number: 1682
    Peptidyl Arginine Deiminase Expression and Macrophage Polarization Following Stimulation with Citrullinated and Malondialdehyde-acetaldehyde Modified Fibrinogen
  • Abstract Number: 1098
    Perceived Barriers and Opportunities to Accessing Rheumatoid Arthritis Care on Navajo Nation: The Primary Care Providers’ Perspectives
  • Abstract Number: 0631
    Perfluoroalkyl Substances and Community Vulnerability: Associations with Lupus-Related Autoantibodies and Disease
  • Abstract Number: 0455
    Performance of 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria in Turkish Vasculitis Patients
  • Abstract Number: 0803
    Performance of Adenosine Deaminase Activity in Sinovial Fluid for the Early Diagnosis of Tuberculous Arthritis: A Meta Analysis
  • Abstract Number: 1774
    Performance of an Early Triage System for Identification of Patients with Inflammatory Rheumatic Diseases
  • Abstract Number: 1037
    Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies
  • Abstract Number: 0392
    Performance of Clinical, Laboratory and Imaging Features for the Diagnosis of Axial Spondyloarthritis – A Systematic Literature Review
  • Abstract Number: 0334
    Performance of Diagnosis Codes for Identification of Prevalent Lupus Nephritis Patients from Electronic Health Records
  • Abstract Number: 0250
    Performance of Fear Assessment in Inflammatory Rheumatic Diseases (FAIR) Questionnaire in a Cohort of Rheumatoid Arthritis Patients in Argentina
  • Abstract Number: 1320
    Performance of FRAX® Brazil and NOGG Methodology with and Without Bone Mineral Density upon Predicting Fractures on a Community-Dwelling Elderly Population with High Incidence of Osteoporotic Fractures: The São Paulo Ageing and Health (SPAH) Study
  • Abstract Number: 1080
    Performance of Risk Prediction Models for Relapse and Severe Infection at the End of 18-month Rituximab Maintenance Therapy in ANCA-associated Vasculitides: Data from the MAINRITSAN Trials
  • Abstract Number: 2238
    Performance of the 2016 ACR/EULAR Myositis Response Criteria in Adult Dermatomyositis and Polymyositis Therapeutic Trials and Consensus Profiles
  • Abstract Number: 0899
    Performance of the Foot Function Index Questionnaire in Patients with Rheumatoid Arthritis
  • Abstract Number: 0612
    Peripheral Blood and Synovial Fluid Natural Killer (NK) and Natural Killer T (NKT) Cell Immunophenotypes in Active Rheumatoid Arthritis and Their Role as Biomarkers of Methotrexate Response
  • Abstract Number: 1116
    Peripheral Blood DNA Methylation-based Machine Learning Models for Prediction of Knee Osteoarthritis Progression: Biospecimens and Data from the Osteoarthritis Initiative and Johnston County Osteoarthritis Project
  • Abstract Number: 1796
    Peripheral Vascular Disease and Sequelae in Individuals with Gout, Diabetes, or Both Among US Veterans
  • Abstract Number: 1724
    Perivascular Adipose Tissue Promotes Vascular Dysfunction in Murine Lupus
  • Abstract Number: 0476
    Permanent Vision Loss in Giant Cell Arteritis: Why the Incidence Remains High
  • Abstract Number: 0204
    Persistence of Fatigue, Sleep Disturbance and Mood Disorders in PMR Patients Despite Standard Treatment
  • Abstract Number: 0754
    Persistent but Disturbed Germinal Center Reaction Among 3rd SARS-CoV-2 Vaccination After Rituximab Exposure
  • Abstract Number: 0390
    Persistent Post-Covid Symptoms in Psoriatic Arthritis Patients
  • Abstract Number: 1432
    Pharmacokinetic Evaluation of a Proposed Adalimumab Biosimilar MSB11022 versus the US-Licensed Reference Product: Results of a Randomized, Double-Blind, 3-Arm Parallel-Group, Single-Dose Trial in Healthy Subjects
  • Abstract Number: 0009
    Pharmacokinetics, Receptor Occupancy, and Pharmacodynamics of Obexelimab Following Intravenous Administration in Adult Healthy Volunteers and in Patients with Rheumatoid Arthritis
  • Abstract Number: 1421
    Pharmacokinetics, Safety, Tolerability, and Immunogenicity of a Proposed Tocilizumab Biosimilar (MSB11456) versus US‑licensed Tocilizumab: Results of a Randomized, Double-blind, Parallel‑group, Single‑intravenous Dose Study in Healthy Adults (APTURA II)
  • Abstract Number: 1670
    Phase II Clinical Trial to Assess the Safety and Efficacy of Tocilizumab in Combination with Ipilimumab and Nivolumab for Treatment-naïve Metastatic Melanoma
  • Abstract Number: 0366
    Phase II Trial of Enpatoran in Patients Hospitalized with COVID-19 Pneumonia
  • Abstract Number: 1851
    Phenotype and Genotype of Adult-onset Adenosine Deaminase 2 Deficiency Patients
  • Abstract Number: 0649
    Phosphofructokinase P Fine-Tunes T Regulatory Cell Metabolism, Function and Stability in Systemic Autoimmunity
  • Abstract Number: 1631
    Phospholipase D 4 Is a Novel Surface Marker of a Distinctive B Cell Population Overlapping with Double Negative 2 B Cells
  • Abstract Number: 0379
    Physical Activity Is Associated with Physical and Global Function in Patients with Axial Spondyloarthritis, Independent of Disease Activity
  • Abstract Number: 2225
    Physical Inactivity Is Associated with Increased Expression of T Cell Inflammatory Genes in Systemic Lupus
  • Abstract Number: 1250
    Physiologic Adaptive Change of the Patellar and Achilles Tendons: Sensitivity to Change Detected by Computer Analysis of Sequential Static Images
  • Abstract Number: 0056
    Pilot Study to Implement the Type 1 & 2 SLE Model in an Academic Rheumatology Clinic
  • Abstract Number: 0939
    Pilot Study: A Novel Method for Cervical Health Monitoring in African American Women with Systemic Lupus Erythematosus (SLE) Using a Self- Sampling Brush to Assess Cervical HPV Infection and Cervical Cytology
  • Abstract Number: 1303
    Planning Transition in Times of Transition: Is There a Virtual Pathway from Pediatric to Adult Care?
  • Abstract Number: PP24
    Planting Seeds of Self-Advocacy: Increasing Healthcare Engagement in Children and Adolescents Through Arthritis Camp
  • Abstract Number: 0903
    Plasma Inflammatory Protein Biomarkers May Predict Cardiovascular Events in Early Rheumatoid Arthritis
  • Abstract Number: 0040
    Plasma Proteomic Signatures in Juvenile Dermatomyositis Highlight Novel Proteins and a Protein Module That Associate with Skin and Global Disease Activity
  • Abstract Number: 2267
    Plasmacytoid Dendritic Cells Are Not Major Producers of Type 1 Interferons in Cutaneous Lupus
  • Abstract Number: 2266
    Platelet-selectin Prime Lupus Neutrophils to Produce Mitochondrial ROS and Participate in SLE Pathogenesis
  • Abstract Number: PP16
    Please Hear Me: How Effective Provider-Patient Communication Improved My Psoriatic Arthritis
  • Abstract Number: 0132
    Pleuroparenchymal Fibroelastosis: A Special Clinical Situation in Patients with Interstitial Lung Disease Associated with Connective Tissue Diseases. Descriptive Study from a Referral Centre
  • Abstract Number: 1982
    Pluripotency Marker PBX1 Predicts Treatment Effect in Rheumatoid Arthritis
  • Abstract Number: 0152
    Pm/Scl Patients Have an Expanded Population of CD19+CD21lo/negCD11c+CD11b+ Cells Expressing a Monocyte, Not B Cell, Transcriptome
  • Abstract Number: 1275
    Pneumococcal Vaccination Compliance Rate Among Lupus and Rheumatoid Arthritis Patients in Rheumatology Fellow’s Cllinic
  • Abstract Number: 1791
    Point-of-Care Multi-Energy Photon-Counting CT for Earlier Non-Invasive Diagnosis of Gout and Calcium Pyrophosphate Deposition Disease
  • Abstract Number: 0137
    Polyarticular Arthritis and Osteolysis Caused by Mutations in the ASAH1 Gene: Farber Disease Clinical Presentations in the First-ever Natural History Study
  • Abstract Number: 1866
    Polymyositis/Dermatomyositis Readmissions: Analysis of the Nationwide Readmission Database
  • Abstract Number: 2074
    Poor Executive Function Correlates with Increased Disease Damage and Impaired Patient-Reported Outcomes in Youth with Childhood-Onset Lupus: A Cross-Sectional Study
  • Abstract Number: 1347
    Poor Health-Related Quality of Life in Patients with Lupus Nephritis
  • Abstract Number: 1580
    Poor Serum Urate Control Is a Driver of Excess Cardiovascular Risk in Patients with Gout
  • Abstract Number: 0709
    Population Based Prevalence and Incidence of Mixed Connective Tissue Disease from the Manhattan Lupus Surveillance Program
  • Abstract Number: 0795
    Post-Acute COVID-19 Sequalae (PACS) with New-onset Rheumatological Complications
  • Abstract Number: 0792
    Post-mRNA Vaccine Flares in Autoimmune Inflammatory Rheumatic Diseases: Results from the COronavirus National Vaccine Registry for ImmuNe Diseases SINGapore (CONVIN-SING)
  • Abstract Number: 0070
    Post-operative Delirium and Cognitive Impairment: An Analysis of Predictors and 120-day Outcomes in England Using the National Hip Fracture Database (NHFD)
  • Abstract Number: 1686
    Post-translational Modification of Matrix-gla Protein with Malondialdehyde-Acetaldehyde Alters Cellular Responses by Human Fibroblasts
  • Abstract Number: 0614
    Post-translationally Modified Fibrinogen Activated Macrophages Drive the Expression of Fibrotic Genes in Rheumatoid Arthritis Fibroblast-Like Synoviocytes
  • Abstract Number: 0848
    Postoperative Flares and Peri-arthroscopic Management of Immunosuppressive Medications in Patients with Rheumatic Disease
  • Abstract Number: 0840
    Postoperative Risk of Immunosuppression in Rheumatic Disease Patients Undergoing Arthroscopy
  • Abstract Number: 0716
    Posttraumatic Stress Disorder Symptoms in Systemic Autoimmune Rheumatic Disease Patients During the Early COVID-19 Pandemic
  • Abstract Number: 0548
    Postural Orthostatic Tachycardia Syndrome, Small Fiber Neuropathy, and Systemic Inflammation: Are They Related?
  • Abstract Number: 1703
    Potential Regulation of NK Cells by CD1c+ Dendritic Cells Through RIG-I/DDX60 Pathway Involved in Th17 Responses in Primary Sjögren Syndrome
  • Abstract Number: 0269
    Practical Cut-off Points for Using the Rheumatoid Arthritis Impact of Disease (RAID) Questionnaire in Remote Consult Triage
  • Abstract Number: 1282
    Practice Patterns for Pneumocystis Jiroveci Pneumonia (PJP) Prophylaxis Among Nephrologists and Rheumatologists – an International Survey Study
  • Abstract Number: 1667
    Pre-existing Rheumatoid Arthritis Patients Initiating Immune Checkpoint Inhibitors for Cancer Treatment: A Comparative Cohort Study Investigating RA Flare and Mortality
  • Abstract Number: 2195
    Pre-exposure Prophylaxis for SARS-CoV-2 with Subcutaneous Casirivimab/Imdevimab in Vaccine-refractory Patients with Immune-mediated Inflammatory Diseases
  • Abstract Number: 1673
    Preconceptional NSAID Treatment Exposure Is Associated with a Significantly Longer Time-to-conception in Women with Spondyloarthritis: Analysis of the Prospective GR2 Cohort
  • Abstract Number: 0905
    Predicting Disease Activity in Rheumatoid Arthritis Patients Using Machine Learning: Data from the ACR’s RISE Registry
  • Abstract Number: 0825
    Predicting Outcomes in Macrophage Activation Syndrome (MAS): A Retrospective Study on 43 Consecutive Patients with MAS
  • Abstract Number: 0328
    Predicting Progression from Undifferentiated to Definitive Connective Tissue Diseases: A Systematic Review and Meta-analysis
  • Abstract Number: 2062
    Predicting Severe Flares: Real-world Application of a Decision-Tree Model Among the Medicaid-Insured Systemic Lupus Erythematosus (SLE) Population in the US
  • Abstract Number: 0858
    Predicting the Occurrence of Drug-Free Inactive Disease Two Years After Diagnosis of Non-Systemic Juvenile Idiopathic Arthritis
  • Abstract Number: 0892
    Predicting Value of Circulating Semaphorin 4A for Rheumatoid Arthritis Progression and Response to Treatment
  • Abstract Number: 1612
    Prediction of Psoriatic Arthritis Tool (PRESTO): Development and Performance of a New Scoring System for Psoriatic Arthritis Risk
  • Abstract Number: 0875
    Predictive Biomarkers of Tofacitinib Response and Disease Activity in Juvenile Idiopathic Arthritis Subtypes: A Longitudinal Study
  • Abstract Number: 1955
    Predictive Factor of Spontaneous Regression in Methotorexate-associated Lymphoproliferative Disorders with RA Patients
  • Abstract Number: 0432
    Predictive Factors of Eosinophilic Granulomatosis with Polyangiitis Long-term Evolution: Data from a European Cohort
  • Abstract Number: 0458
    Predictive Models for Thromboembolic Events in Giant Cell Arteritis: A US Veterans Health Administration Population-Based Study
  • Abstract Number: 0817
    Predictive Severity Factors of COVID-19 in Patients with Rheumatic Immune Mediated Diseases
  • Abstract Number: 1436
    Predictors at Diagnosis for Start of Biologic Disease Modifying Anti-Rheumatic Drugs in Patients with Early Rheumatoid Arthritis
  • Abstract Number: 1411
    Predictors of Achieving Clinical Remission in ACPA-positive RA-patients Treated with Abatacept and Methotrexate or Methotrexate Monotherapy
  • Abstract Number: 1989
    Predictors of Flare in the RHEUmatoid Arthritis Medication TAPering (RHEUMTAP) Cohort
  • Abstract Number: 0262
    Predictors of Fragility Fracture Amongst Patients with Rheumatoid Arthritis: An Observational Cohort Study
  • Abstract Number: 2094
    Predictors of Health-Related Quality of Life (HRQoL) in Adults with Juvenile- and Adult-onset Systemic Lupus Erythematosus: Results from a Multiethnic US Cohort (LUMINA)
  • Abstract Number: 0919
    Predictors of Methotrexate Monotherapy Response in Patients with Active Rheumatoid Arthritis: Results from a Multicentre, Randomized Controlled Trial
  • Abstract Number: 0845
    Predictors of Moderate-Vigorous Physical Activity Following a Physical Therapist Led Physical Activity Intervention for Adults with Total Knee Replacement
  • Abstract Number: 1015
    Predictors of Nail Response with Guselkumab: A Post Hoc Analysis of the VOYAGE 2 Clinical Trial
  • Abstract Number: 2067
    Predictors of Organ Damage Accrual by Domains
  • Abstract Number: 2012
    Predictors of Remission in Rheumatoid Arthritis Patients Treated with Biologics: A Systematic Review and Meta-analysis
  • Abstract Number: 1987
    Prednisone Use and the Incidence of Hyperglycemia or Diabetes in Patients with Rheumatoid Arthritis; A 10-year Sub Analysis of the BeSt Study
  • Abstract Number: 0952
    Pregnancy Course and Outcomes of Patients with Polymyositis and Dermatomyositis (PM/DM) in Our Institution
  • Abstract Number: 2107
    Pregnancy Outcomes Among Women with Systemic Lupus Erythematosus (SLE): Impact of Preexisting Hypertension
  • Abstract Number: 0965
    Pregnancy Outcomes in a Diverse Lupus Cohort
  • Abstract Number: 0370
    Preliminary Findings from a Randomized Clinical Trial Show a Remotely Delivered Psychological Intervention May Be Beneficial to Youth with Childhood-Onset Lupus
  • Abstract Number: 0741
    Prescribing Patterns of SGLT2 Inhibitors for Patients with Autoimmune Rheumatic Disease
  • Abstract Number: 1581
    Presence of Sonographic Crystal Deposits and Power-Doppler Signal in Patients with Gout Fulfilling Remission Criteria: A Multicenter Study
  • Abstract Number: 0676
    Presentation and Outcomes in Patients with Adrenal Hemorrhage Associated with Antiphospholipid Syndrome: A Cohort Study and Systematic Review of Literature
  • Abstract Number: 1453
    Prevalence and Associations of Myositis in an Indian Inception Cohort of Lupus
  • Abstract Number: 1943
    Prevalence and Evolution of Undifferentiated Periodic Fever Syndromes in an Academic Pediatric Rheumatology Practice
  • Abstract Number: 1218
    Prevalence and Impact of Widespread Pain and Fibromyalgia on Measurement of Disease Severity in Psoriatic Arthritis: Lessons from the CorEvitas Registry
  • Abstract Number: 1770
    Prevalence and Incidence of Depression in Patients with Rheumatoid Arthritis: A Systematic Review
  • Abstract Number: 2248
    Prevalence and Mortality of Interstitial Lung Abnormalities in Rheumatoid Arthritis and non-RA Comparators in a Multicenter Prospective Cohort
  • Abstract Number: 1477
    Prevalence and Risk Factors of Fragility Fractures in Systemic Lupus Erythematosus: A Longitudinal Study over 12 Years
  • Abstract Number: 1308
    Prevalence and Therapeutic Practices of Osteoporosis in Sarcoidosis in the United States: A Nationwide Registry Study
  • Abstract Number: 0760
    Prevalence of Autoimmune Conditions in Metastatic Melanoma Patients Starting Checkpoint Inhibitors
  • Abstract Number: 0378
    Prevalence of Axial Spondyloarthritis (axSpA) in Patients Treated for Chronic Back Pain in Chiropractic Clinics
  • Abstract Number: 1329
    Prevalence of Bone Fragility on DXA and CT in Patients with Obesity
  • Abstract Number: 0444
    Prevalence of Frailty and Associated Factors in Patients with Vasculitis
  • Abstract Number: 0674
    Prevalence of Heparin Induced Thrombocytopenia in Hospitalized Patients with Antiphospholipid Syndrome or Systemic Lupus Erythematosus with Antiphospholipid Antibodies
  • Abstract Number: 1793
    Prevalence of HLA B*5801 Allele Among African American Patients with Gout in an Academic Health Center
  • Abstract Number: 1441
    Prevalence of Secondary Connective Tissue Diseases and Autoantibodies Among Racial and Ethnic Groups in Systemic Lupus Erythematosus Patients in the Manhattan Lupus Surveillance Program
  • Abstract Number: 0541
    Prevalence of Venous Thrombo-Embolism in Lupus Nephritis and Associated Risk Factors
  • Abstract Number: 1558
    Prevalence, Phenotypical Clinical Clusters and Treatment of Neurobehçet’s Disease: Study in Northern Spain
  • Abstract Number: 1518
    Prevalence, Risk Factors and Treatment Patterns of Digital Ischemic Complications in Systemic Sclerosis: A Single Center Cross-Sectional Study
  • Abstract Number: 0231
    Primary Care Physician’s Perspective and Needs on Early Rheumatoid Arthritis Diagnosis: REUCARE Program for Early Referral
  • Abstract Number: 0222
    Primary Care Provider Utilization of Musculoskeletal Ultrasound for the Diagnosis of Acute Gout Flares: A Novel Opportunity for Rheumatology-Focused Educational Curricula
  • Abstract Number: 2199
    Primary Non-adherence to Biologics and Immunomodulatory Therapies for Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis Using Linked EHR and Pharmacy Claims Data
  • Abstract Number: 0727
    Primary Prevention of Fractures in Osteoporotic Patients in a Southern California Academic Health System
  • Abstract Number: 0991
    Prior Use of Autoimmune Disease Treatments Among Patients with Systemic Lupus Erythematosus, Rheumatoid Arthritis, or Myositis Hospitalized with COVID-19
  • Abstract Number: 1349
    Priority Educational Topics to Deliver Information About Immune Checkpoint Inhibitors for Patients with Cancer and a Pre-Existing Autoimmune Disease
  • Abstract Number: 2247
    Priority Research Topics for Vaccine Uptake Among Adults with Autoimmune Conditions
  • Abstract Number: 1620
    Probability-based Diagnostic Algorithm in Suspected Giant Cell Arteritis: A Prospective, Multicentre Validity Data from HAS GCA Study
  • Abstract Number: 0235
    Procedure-Based Musculoskeletal Ultrasound Curriculum for Rheumatology Fellows
  • Abstract Number: 1336
    Productivity Analysis in Patients with Idiopathic Inflammatory Myopathies and Relationship with Quality of Life and Emotional Domain: Preliminary Data from a Monocentric Cohort
  • Abstract Number: 2164
    Profibrotic Alveolar Macrophages as a Potential Biomarker in Systemic Sclerosis-associated Interstitial Lung Disease
  • Abstract Number: 0547
    Profiling of Systemic Immune Responses in Axial Spondyloarthritis Patients Reveals Strikingly Distinct Cellular and Molecular Mechanisms of Action of IL-17A Inhibitors and TNF-Blockers
  • Abstract Number: 1605
    Profound Anticoagulant Effects of Initial Antirheumatic Treatments in Early Rheumatoid Arthritis Patients; A NORD-STAR Spin-off Study
  • Abstract Number: 0443
    Prognosis of Non-PR3 ANCA-Associated Vasculitis with Glomerulonephritis
  • Abstract Number: 1319
    Prognostic Utility of Metacarpal Bone Mineral Density Measurement in Patients with Recent-onset Arthritis by Assessment of Radiographic Progression at 2-year Follow Up
  • Abstract Number: 1089
    Prognostic Value of Proteinuria Monitoring in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
  • Abstract Number: 1536
    Progressive Interstitial Lung Disease Is Frequent Also in Late Disease Stages in Systemic Sclerosis Patients from EUSTAR
  • Abstract Number: 1785
    PROs and Sociodemographic Factors in Year Prior to COVID Predict Trajectories of Depressive Symptoms in Adults with RA in First 2 Years of Pandemic: Data from the Canadian Early Arthritis Cohort
  • Abstract Number: 2087
    Prospective Study of Clinical, Laboratory, and Patient-Reported Outcomes of Patients with Systemic Lupus Erythematosus Undergoing Total Hip and Total Knee Arthroplasty
  • Abstract Number: 1721
    Protective Effects of the Natural Antioxidant Taxifolin in Models of Lupus and Antiphospholipid Syndrome
  • Abstract Number: 0055
    Protective Role for Mast Cells in TNF-induced Inflammatory-Erosive Arthritis and Its Associated Lymphatic Dysfunction in Mice
  • Abstract Number: 0655
    Proteomic Analysis of Histological Lesions Lupus Nephritis Identifies an Inflammatory Signature of Fibrous Crescents
  • Abstract Number: 1163
    Proteomic Investigation to Identify Urinary Biomarker for Ankylosing Spondylitis
  • Abstract Number: 1537
    Proteomic Profiling of Plasma Microvesicles Isolated from Patients with Systemic Sclerosis
  • Abstract Number: 0611
    Proteomics Reveals Dysregulated Molecular Mechanisms of Cell Death in Neutrophils in Rheumatoid Arthritis
  • Abstract Number: 0837
    Providers’ Adoption of 2017 Guidelines on DMARD Use Perioperatively for Elective Total Hip and Knee Arthroplasty at a Single Academic Center
  • Abstract Number: L04
    Psoriatic Arthritis Disease Subtypes Mediated by CD8 T Cells Are Phenocopied in a Novel Humanized Murine Model of Psoriasis and Arthritis
  • Abstract Number: 1779
    Psychosocial and Health Measures in Systemic Lupus Erythematosus: COVID-19 Pandemic Trends in the Georgians Organized Against Lupus Cohort
  • Abstract Number: 2172
    Pulmonary Function in Patients Diagnosed of Early Systemic Sclerosis: 10 Years-Experience
  • Abstract Number: 1090
    Pulmonary Function Testing (PFT) in Patients with Antineutrophil Cytoplasmic Antibodies (ANCA)-associated Vasculitis (AAV): Correlation with Radiologic Imaging
  • Abstract Number: 0823
    Pulmonary Manifestations in VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome: A Systematic Literature Review
  • Abstract Number: 1788
    Pulmonary Vascular Dysfunction Occurs in Association with Hyperuricaemia: Assessment by a Novel Non-Invasive Measurement of Pulmonary Pulse Wave Transit Time
  • Abstract Number: 1611
    Putative Role of the Histidine and Tryptophan Biochemical Pathways in the Mode of Action of Upadacitinib in Patients with Ankylosing Spondylitis
Jump to:  View All • a b c d e f g h i j k l m n o [p] q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology